查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434617

过敏性鼻炎治疗药物市场：按给药途径、药物类别和应用分类 - 全球预测 2024-2030

Allergic Rhinitis Drugs Market by Route of Administration (Intranasal, Intraocular, Oral), Class of Drugs (Antihistamines, Immunotherapies, Intranasal Corticosteroids), Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年过敏性鼻炎治疗药物市场规模为47.5亿美元，2024年达49.7亿美元，预计2030年将达65.9亿美元，复合年增长率为4.77%。

过敏性鼻炎治疗药物的全球市场

主要市场统计
基准年[2023] 47.5亿美元
预测年份 [2024] 49.7亿美元
预测年份 [2030] 65.9亿美元
复合年增长率（%） 4.77%
过敏性鼻炎治疗药物市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估过敏性鼻炎治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对过敏性鼻炎治疗药物市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-过敏性鼻炎治疗药物市场的市场规模和预测是多少？

2-在过敏性鼻炎治疗药物市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-过敏性鼻炎治疗药物市场的技术趋势和法律规范是什么？

4-过敏性鼻炎治疗药物市场主要供应商的市场占有率是多少？

5-进入过敏性鼻炎治疗药物市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 过敏性鼻炎盛行率上升
      • 吸烟增加导致的生活方式改变会促进过敏性鼻炎
      • 随着滴鼻剂等各种给药方法的出现，对过敏性鼻炎治疗的需求增加
      • 对成药的需求
    • 抑制因素
      • 过敏性鼻炎症状的特异性降低
    • 机会
      • 扩大过敏性鼻炎治疗药物的开发与商业化
      • 加强政府和组织的努力，提高对过敏性鼻炎的认识
    • 任务
      • 过敏性鼻炎没有标准治疗方法。
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 过敏性鼻炎治疗药物市场：依给药途径

  • 鼻内
  • 眼
  • 口服
  • 胃肠外的

第七章依药物类别分類的过敏性鼻炎治疗药物市场

  • 抗组织胺药
  • 免疫疗法
  • 鼻内皮质类固醇

第八章过敏性鼻炎治疗药物市场：依应用分类

  • 医院药房
  • 网路药房
  • 零售药房

第九章北美和南美过敏性鼻炎治疗药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区过敏性鼻炎治疗药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章：欧洲、中东和非洲的过敏性鼻炎治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Adamis Pharmaceuticals
    • Alcon, Inc.
    • Apotex Inc.
    • Ascend Laboratories LLC by The Pharma Network, LLC
    • Dr. Reddy's Laboratories, Ltd.
    • Gland Pharma Limited
    • GlaxoSmithKline PLC
    • Hikma Pharmaceuticals PLC
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Mitsubishi Tanabe Pharma Corporation
    • Sandoz International GmbH by Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Unichem Laboratories Ltd.
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-436901065A1E

[194 Pages Report] The Allergic Rhinitis Drugs Market size was estimated at USD 4.75 billion in 2023 and expected to reach USD 4.97 billion in 2024, at a CAGR 4.77% to reach USD 6.59 billion by 2030.

Global Allergic Rhinitis Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 4.75 billion
Estimated Year [2024] USD 4.97 billion
Forecast Year [2030] USD 6.59 billion
CAGR (%) 4.77%
Allergic Rhinitis Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Allergic Rhinitis Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergic Rhinitis Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Allergic Rhinitis Drugs Market, highlighting leading vendors and their innovative profiles. These include Adamis Pharmaceuticals, Alcon, Inc., Apotex Inc., Ascend Laboratories LLC by The Pharma Network, LLC, Dr. Reddy's Laboratories, Ltd., Gland Pharma Limited, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Sandoz International GmbH by Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Unichem Laboratories Ltd..

Market Segmentation & Coverage

This research report categorizes the Allergic Rhinitis Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Intranasal
    • Intraocular
    • Oral
    • Parenteral
  • Class of Drugs
    • Antihistamines
    • Immunotherapies
    • Intranasal Corticosteroids
  • Application
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Allergic Rhinitis Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergic Rhinitis Drugs Market?

3. What are the technology trends and regulatory frameworks in the Allergic Rhinitis Drugs Market?

4. What is the market share of the leading vendors in the Allergic Rhinitis Drugs Market?

5. Which modes and strategic moves are suitable for entering the Allergic Rhinitis Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Allergic Rhinitis Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of allergic rhinitis
      • 5.1.1.2. Increasing lifestyle changes attributes to growing use of tobacco promotes allergic rhinitis
      • 5.1.1.3. Availability of different modes of administration such as nasal sprays increases demand for allergic rhinitis drugs
      • 5.1.1.4. Demand for over-the-counter drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced specificity of symptoms for allergic rhinitis
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development and commercialization of allergic rhinitis drugs
      • 5.1.3.2. Increasing government and organization initiatives to increase the awareness of allergic rhinitis
    • 5.1.4. Challenges
      • 5.1.4.1. No standard cure for allergic rhinitis
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Allergic Rhinitis Drugs Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intranasal
  • 6.3. Intraocular
  • 6.4. Oral
  • 6.5. Parenteral

7. Allergic Rhinitis Drugs Market, by Class of Drugs

  • 7.1. Introduction
  • 7.2. Antihistamines
  • 7.3. Immunotherapies
  • 7.4. Intranasal Corticosteroids

8. Allergic Rhinitis Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Americas Allergic Rhinitis Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Allergic Rhinitis Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Allergic Rhinitis Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Adamis Pharmaceuticals
    • 13.1.2. Alcon, Inc.
    • 13.1.3. Apotex Inc.
    • 13.1.4. Ascend Laboratories LLC by The Pharma Network, LLC
    • 13.1.5. Dr. Reddy's Laboratories, Ltd.
    • 13.1.6. Gland Pharma Limited
    • 13.1.7. GlaxoSmithKline PLC
    • 13.1.8. Hikma Pharmaceuticals PLC
    • 13.1.9. Johnson & Johnson Services, Inc.
    • 13.1.10. Merck & Co., Inc.
    • 13.1.11. Mitsubishi Tanabe Pharma Corporation
    • 13.1.12. Sandoz International GmbH by Novartis AG
    • 13.1.13. Sun Pharmaceutical Industries Ltd.
    • 13.1.14. Teva Pharmaceutical Industries Ltd.
    • 13.1.15. Unichem Laboratories Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ALLERGIC RHINITIS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGIC RHINITIS DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALLERGIC RHINITIS DRUGS MARKET DYNAMICS
  • FIGURE 7. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2030 (%)
  • FIGURE 10. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ALLERGIC RHINITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALLERGIC RHINITIS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALLERGIC RHINITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 11. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY INTRANASAL CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ALLERGIC RHINITIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ALLERGIC RHINITIS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. ALLERGIC RHINITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 146. ALLERGIC RHINITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ALLERGIC RHINITIS DRUGS MARKET LICENSE & PRICING